Press Center

Find Novavax’s press releases, statements and materials for journalists.

Apply filter
Apr 15, 2025
COVID-19

SHIELD-Utah Study Shows Novavax's COVID-19 Vaccine Induces Lower Reactogenicity Symptoms Compared to mRNA

Read full article
Download
Apr 10, 2025
Statement
COVID-19

Update on Status of Novavax's COVID-19 Vaccine BLA

Read full article
Download
Apr 2, 2025
Statement
COVID-19

Update on U.S. FDA BLA for Novavax's COVID-19 Vaccine

Read full article
Download
All press releases
In the News

See what others are saying about Novavax. 

Note: This section features articles written by independent and external media outlets and journalists.

PharmaVoice

The industry heavyweight behind Novavax’s push to bounce back

Read the article

BioSpace

Two Years Into Novavax Reset, CEO Jacobs Hunts for Silver Lining

Read the article

BiotechTV

After striking a transformational deal with Sanofi, Novavax is ramping up its vaccine pipeline

Read the article

Chief Influencer

Silvia Taylor on Championing Science and Staying the Course

Read the article

Yahoo Finance

Novavax stock plunges after quarterly earnings, but company sees hope in licensing deals

Read the article

Washington Business Journal

The turnaround man, John Jacobs is reshaping Novavax for the post-pandemic era

Read the article

Media contact

Email: [email protected]
Phone: (202) 709-5563

Patient getting shot in arm
scientist in lab
two scientists in a lab

Images, videos, and files for media use

Extensive materials for members of the press, including broadcast, online, film, radio and print journalists.

Explore & download

About Novavax

Novavax, Inc. (Nasdaq: NVAX) is a global biotechnology company focused on using our proven vaccine technology to help protect health through the development of our R&D assets and establishing partnerships

Who we are